Clinical application of positron emission tomography/computed tomography in hepatocellular carcinoma and related research advances
Hepatocellular carcinoma (HCC) has a high fatality rate and most patients are in advanced stage when diagnosed with routine methods. As a molecular imaging method, positron emission tomography/computed tomography (PET/CT) has become more and more important. However, it also has certain limitations,...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2017-07-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8335 |
| Summary: | Hepatocellular carcinoma (HCC) has a high fatality rate and most patients are in advanced stage when diagnosed with routine methods. As a molecular imaging method, positron emission tomography/computed tomography (PET/CT) has become more and more important. However, it also has certain limitations, since it always has false-negative results for well-differentiated HCC and small HCC. Therefore, a combination of various tracers can improve the sensitivity and specificity of PET/CT in the diagnosis of HCC. This article reviews the role of PET/CT in the therapeutic effect evaluation, recurrence monitoring, and prognosis of HCC.
|
|---|---|
| ISSN: | 1001-5256 1001-5256 |